Response to FDA Commissioner's statement on Dsuvia approval
Michael H Bernstein, Francesca L Beaudoin, Molly Magill, Michael H Bernstein, Francesca L Beaudoin, Molly Magill
No abstract availableKeywords: Dsuvia; Sufentanil; medication; opioid; opioid crisis; prescription opioid.
Conflict of interest statement
Competing Interests: None
Source: PubMed